FROME MEDICAL CENTRE
ENOS WAY, FROMEHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 41 | 53 | 77.4% | |
HF 4 | 2011 | 46 | 68 | 67.6% | |
HF 4 | 2012 | 52 | 58 | 89.7% | |
HF 4 | 2013 | 53 | 63 | 84.1% | |
HF004 | 2014 | 7 | 8 | 87.5% | |
HF004 | 2015 | 11 | 12 | 91.7% | |
HF004 | 2016 | 12 | 13 | 92.3% | |
HF004 | 2017 | 16 | 18 | 88.9% | |
HF004 | 2018 | 116 | 141 | 82.3% | |
HF004 | 2019 | 140 | 163 | 85.9% | |
HF004 | 2020 | 141 | 163 | 86.5% | |
HF006 | 2021 | 182 | 195 | 93.3% | |
HF006 | 2022 | 180 | 189 | 95.2% | |
HF006 | 2023 | 172 | 184 | 93.5% |